nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A7—Sorafenib—thyroid cancer	0.155	0.203	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.155	0.203	CbGbCtD
Dextropropoxyphene—CYP2C8—Sorafenib—thyroid cancer	0.112	0.147	CbGbCtD
Dextropropoxyphene—CYP2C9—Sorafenib—thyroid cancer	0.0782	0.102	CbGbCtD
Dextropropoxyphene—CYP3A4—Vandetanib—thyroid cancer	0.0754	0.0987	CbGbCtD
Dextropropoxyphene—CYP2D6—Sorafenib—thyroid cancer	0.0715	0.0935	CbGbCtD
Dextropropoxyphene—CYP3A4—Sorafenib—thyroid cancer	0.0455	0.0595	CbGbCtD
Dextropropoxyphene—CYP2D6—Doxorubicin—thyroid cancer	0.0434	0.0567	CbGbCtD
Dextropropoxyphene—CYP3A4—Doxorubicin—thyroid cancer	0.0276	0.0361	CbGbCtD
Dextropropoxyphene—Cardio-respiratory arrest—Vandetanib—thyroid cancer	0.0178	0.0755	CcSEcCtD
Dextropropoxyphene—Respiratory arrest—Vandetanib—thyroid cancer	0.0144	0.0613	CcSEcCtD
Dextropropoxyphene—Completed suicide—Sorafenib—thyroid cancer	0.00729	0.0309	CcSEcCtD
Dextropropoxyphene—Drug interaction—Sorafenib—thyroid cancer	0.00462	0.0196	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.00461	0.0196	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Vandetanib—thyroid cancer	0.00438	0.0186	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00356	0.0151	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00343	0.0146	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00336	0.0143	CcSEcCtD
Dextropropoxyphene—Bradycardia—Vandetanib—thyroid cancer	0.00325	0.0138	CcSEcCtD
Dextropropoxyphene—Visual impairment—Vandetanib—thyroid cancer	0.00307	0.013	CcSEcCtD
Dextropropoxyphene—Eye disorder—Vandetanib—thyroid cancer	0.00298	0.0126	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Vandetanib—thyroid cancer	0.00296	0.0126	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Vandetanib—thyroid cancer	0.00287	0.0122	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Vandetanib—thyroid cancer	0.00285	0.0121	CcSEcCtD
Dextropropoxyphene—Malnutrition—Vandetanib—thyroid cancer	0.00278	0.0118	CcSEcCtD
Dextropropoxyphene—Vision blurred—Vandetanib—thyroid cancer	0.00262	0.0111	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Vandetanib—thyroid cancer	0.00244	0.0104	CcSEcCtD
Dextropropoxyphene—Convulsion—Vandetanib—thyroid cancer	0.00241	0.0102	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00236	0.01	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Sorafenib—thyroid cancer	0.00235	0.00997	CcSEcCtD
Dextropropoxyphene—Jaundice—Sorafenib—thyroid cancer	0.00234	0.00991	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00227	0.00962	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Epirubicin—thyroid cancer	0.00224	0.00949	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Vandetanib—thyroid cancer	0.00222	0.00943	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Doxorubicin—thyroid cancer	0.00207	0.00878	CcSEcCtD
Dextropropoxyphene—Insomnia—Vandetanib—thyroid cancer	0.00205	0.0087	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Vandetanib—thyroid cancer	0.00202	0.00857	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Sorafenib—thyroid cancer	0.002	0.00847	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Vandetanib—thyroid cancer	0.00199	0.00846	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00196	0.0083	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Sorafenib—thyroid cancer	0.00194	0.00825	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Sorafenib—thyroid cancer	0.00194	0.00823	CcSEcCtD
Dextropropoxyphene—Constipation—Vandetanib—thyroid cancer	0.00194	0.00822	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Sorafenib—thyroid cancer	0.00192	0.00816	CcSEcCtD
Dextropropoxyphene—Liver injury—Epirubicin—thyroid cancer	0.00188	0.00799	CcSEcCtD
Dextropropoxyphene—Malnutrition—Sorafenib—thyroid cancer	0.00187	0.00795	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00185	0.00786	CcSEcCtD
Dextropropoxyphene—Jaundice cholestatic—Epirubicin—thyroid cancer	0.0018	0.00765	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Vandetanib—thyroid cancer	0.00179	0.0076	CcSEcCtD
Dextropropoxyphene—Liver injury—Doxorubicin—thyroid cancer	0.00174	0.00739	CcSEcCtD
Dextropropoxyphene—Syncope—Sorafenib—thyroid cancer	0.00168	0.00713	CcSEcCtD
Dextropropoxyphene—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00167	0.00708	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Sorafenib—thyroid cancer	0.00165	0.00699	CcSEcCtD
Dextropropoxyphene—Asthenia—Vandetanib—thyroid cancer	0.00163	0.0069	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Epirubicin—thyroid cancer	0.00158	0.00672	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Vandetanib—thyroid cancer	0.00155	0.00658	CcSEcCtD
Dextropropoxyphene—Shock—Sorafenib—thyroid cancer	0.0015	0.00638	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Sorafenib—thyroid cancer	0.0015	0.00636	CcSEcCtD
Dextropropoxyphene—Dizziness—Vandetanib—thyroid cancer	0.0015	0.00636	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00147	0.00622	CcSEcCtD
Dextropropoxyphene—Coma—Epirubicin—thyroid cancer	0.00145	0.00614	CcSEcCtD
Dextropropoxyphene—Vomiting—Vandetanib—thyroid cancer	0.00144	0.00611	CcSEcCtD
Dextropropoxyphene—Rash—Vandetanib—thyroid cancer	0.00143	0.00606	CcSEcCtD
Dextropropoxyphene—Dermatitis—Vandetanib—thyroid cancer	0.00143	0.00606	CcSEcCtD
Dextropropoxyphene—Headache—Vandetanib—thyroid cancer	0.00142	0.00602	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Sorafenib—thyroid cancer	0.00136	0.00578	CcSEcCtD
Dextropropoxyphene—Nausea—Vandetanib—thyroid cancer	0.00135	0.00571	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Sorafenib—thyroid cancer	0.00135	0.00571	CcSEcCtD
Dextropropoxyphene—Coma—Doxorubicin—thyroid cancer	0.00134	0.00568	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00132	0.0056	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00132	0.00558	CcSEcCtD
Dextropropoxyphene—Constipation—Sorafenib—thyroid cancer	0.00131	0.00555	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00127	0.00538	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00125	0.0053	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00122	0.00516	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Sorafenib—thyroid cancer	0.00121	0.00513	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00117	0.00498	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00115	0.00488	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Sorafenib—thyroid cancer	0.00113	0.00478	CcSEcCtD
Dextropropoxyphene—Asthenia—Sorafenib—thyroid cancer	0.0011	0.00465	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Epirubicin—thyroid cancer	0.00109	0.00464	CcSEcCtD
Dextropropoxyphene—Ataxia—Epirubicin—thyroid cancer	0.00108	0.00459	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00106	0.00451	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Epirubicin—thyroid cancer	0.00106	0.0045	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Sorafenib—thyroid cancer	0.00105	0.00444	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Doxorubicin—thyroid cancer	0.00101	0.00429	CcSEcCtD
Dextropropoxyphene—Dizziness—Sorafenib—thyroid cancer	0.00101	0.00429	CcSEcCtD
Dextropropoxyphene—Ataxia—Doxorubicin—thyroid cancer	0.001	0.00424	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000982	0.00417	CcSEcCtD
Dextropropoxyphene—Vomiting—Sorafenib—thyroid cancer	0.000972	0.00412	CcSEcCtD
Dextropropoxyphene—Rash—Sorafenib—thyroid cancer	0.000964	0.00409	CcSEcCtD
Dextropropoxyphene—Dermatitis—Sorafenib—thyroid cancer	0.000963	0.00409	CcSEcCtD
Dextropropoxyphene—Headache—Sorafenib—thyroid cancer	0.000958	0.00406	CcSEcCtD
Dextropropoxyphene—Nausea—Sorafenib—thyroid cancer	0.000908	0.00385	CcSEcCtD
Dextropropoxyphene—Drowsiness—Epirubicin—thyroid cancer	0.000886	0.00376	CcSEcCtD
Dextropropoxyphene—Jaundice—Epirubicin—thyroid cancer	0.000863	0.00366	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000838	0.00355	CcSEcCtD
Dextropropoxyphene—Drowsiness—Doxorubicin—thyroid cancer	0.00082	0.00348	CcSEcCtD
Dextropropoxyphene—Bradycardia—Epirubicin—thyroid cancer	0.00081	0.00344	CcSEcCtD
Dextropropoxyphene—Jaundice—Doxorubicin—thyroid cancer	0.000799	0.00339	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000775	0.00329	CcSEcCtD
Dextropropoxyphene—Visual impairment—Epirubicin—thyroid cancer	0.000766	0.00325	CcSEcCtD
Dextropropoxyphene—Bradycardia—Doxorubicin—thyroid cancer	0.000749	0.00318	CcSEcCtD
Dextropropoxyphene—Eye disorder—Epirubicin—thyroid cancer	0.000743	0.00315	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Epirubicin—thyroid cancer	0.000738	0.00313	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Epirubicin—thyroid cancer	0.000718	0.00305	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Epirubicin—thyroid cancer	0.000717	0.00304	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Epirubicin—thyroid cancer	0.00071	0.00301	CcSEcCtD
Dextropropoxyphene—Visual impairment—Doxorubicin—thyroid cancer	0.000709	0.00301	CcSEcCtD
Dextropropoxyphene—Malnutrition—Epirubicin—thyroid cancer	0.000692	0.00294	CcSEcCtD
Dextropropoxyphene—Eye disorder—Doxorubicin—thyroid cancer	0.000688	0.00292	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Doxorubicin—thyroid cancer	0.000683	0.0029	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Doxorubicin—thyroid cancer	0.000665	0.00282	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000663	0.00281	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Doxorubicin—thyroid cancer	0.000657	0.00279	CcSEcCtD
Dextropropoxyphene—Vision blurred—Epirubicin—thyroid cancer	0.000652	0.00277	CcSEcCtD
Dextropropoxyphene—Malnutrition—Doxorubicin—thyroid cancer	0.000641	0.00272	CcSEcCtD
Dextropropoxyphene—Agitation—Epirubicin—thyroid cancer	0.000636	0.0027	CcSEcCtD
Dextropropoxyphene—Syncope—Epirubicin—thyroid cancer	0.000621	0.00263	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Epirubicin—thyroid cancer	0.000608	0.00258	CcSEcCtD
Dextropropoxyphene—Vision blurred—Doxorubicin—thyroid cancer	0.000604	0.00256	CcSEcCtD
Dextropropoxyphene—Convulsion—Epirubicin—thyroid cancer	0.0006	0.00254	CcSEcCtD
Dextropropoxyphene—Agitation—Doxorubicin—thyroid cancer	0.000589	0.0025	CcSEcCtD
Dextropropoxyphene—Discomfort—Epirubicin—thyroid cancer	0.000582	0.00247	CcSEcCtD
Dextropropoxyphene—Syncope—Doxorubicin—thyroid cancer	0.000574	0.00244	CcSEcCtD
Dextropropoxyphene—Confusional state—Epirubicin—thyroid cancer	0.00057	0.00242	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Doxorubicin—thyroid cancer	0.000563	0.00239	CcSEcCtD
Dextropropoxyphene—Shock—Epirubicin—thyroid cancer	0.000556	0.00236	CcSEcCtD
Dextropropoxyphene—Convulsion—Doxorubicin—thyroid cancer	0.000555	0.00235	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Epirubicin—thyroid cancer	0.000554	0.00235	CcSEcCtD
Dextropropoxyphene—Tachycardia—Epirubicin—thyroid cancer	0.000551	0.00234	CcSEcCtD
Dextropropoxyphene—Discomfort—Doxorubicin—thyroid cancer	0.000539	0.00229	CcSEcCtD
Dextropropoxyphene—Hypotension—Epirubicin—thyroid cancer	0.000528	0.00224	CcSEcCtD
Dextropropoxyphene—Confusional state—Doxorubicin—thyroid cancer	0.000527	0.00224	CcSEcCtD
Dextropropoxyphene—Shock—Doxorubicin—thyroid cancer	0.000514	0.00218	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Doxorubicin—thyroid cancer	0.000513	0.00218	CcSEcCtD
Dextropropoxyphene—Insomnia—Epirubicin—thyroid cancer	0.000511	0.00217	CcSEcCtD
Dextropropoxyphene—Tachycardia—Doxorubicin—thyroid cancer	0.00051	0.00216	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Epirubicin—thyroid cancer	0.000504	0.00214	CcSEcCtD
Dextropropoxyphene—Somnolence—Epirubicin—thyroid cancer	0.000502	0.00213	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Epirubicin—thyroid cancer	0.000497	0.00211	CcSEcCtD
Dextropropoxyphene—Hypotension—Doxorubicin—thyroid cancer	0.000488	0.00207	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000488	0.00207	CcSEcCtD
Dextropropoxyphene—Constipation—Epirubicin—thyroid cancer	0.000483	0.00205	CcSEcCtD
Dextropropoxyphene—Insomnia—Doxorubicin—thyroid cancer	0.000473	0.00201	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Doxorubicin—thyroid cancer	0.000466	0.00198	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Epirubicin—thyroid cancer	0.000466	0.00198	CcSEcCtD
Dextropropoxyphene—Somnolence—Doxorubicin—thyroid cancer	0.000465	0.00197	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000462	0.00196	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Doxorubicin—thyroid cancer	0.00046	0.00195	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000451	0.00191	CcSEcCtD
Dextropropoxyphene—Constipation—Doxorubicin—thyroid cancer	0.000447	0.0019	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Epirubicin—thyroid cancer	0.000447	0.0019	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Doxorubicin—thyroid cancer	0.000431	0.00183	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000427	0.00181	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Epirubicin—thyroid cancer	0.000416	0.00177	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Doxorubicin—thyroid cancer	0.000413	0.00175	CcSEcCtD
Dextropropoxyphene—Asthenia—Epirubicin—thyroid cancer	0.000405	0.00172	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Epirubicin—thyroid cancer	0.000387	0.00164	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Doxorubicin—thyroid cancer	0.000385	0.00163	CcSEcCtD
Dextropropoxyphene—Asthenia—Doxorubicin—thyroid cancer	0.000375	0.00159	CcSEcCtD
Dextropropoxyphene—Dizziness—Epirubicin—thyroid cancer	0.000374	0.00159	CcSEcCtD
Dextropropoxyphene—Vomiting—Epirubicin—thyroid cancer	0.000359	0.00152	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Doxorubicin—thyroid cancer	0.000358	0.00152	CcSEcCtD
Dextropropoxyphene—Rash—Epirubicin—thyroid cancer	0.000356	0.00151	CcSEcCtD
Dextropropoxyphene—Dermatitis—Epirubicin—thyroid cancer	0.000356	0.00151	CcSEcCtD
Dextropropoxyphene—Headache—Epirubicin—thyroid cancer	0.000354	0.0015	CcSEcCtD
Dextropropoxyphene—Dizziness—Doxorubicin—thyroid cancer	0.000346	0.00147	CcSEcCtD
Dextropropoxyphene—Nausea—Epirubicin—thyroid cancer	0.000336	0.00142	CcSEcCtD
Dextropropoxyphene—Vomiting—Doxorubicin—thyroid cancer	0.000332	0.00141	CcSEcCtD
Dextropropoxyphene—Rash—Doxorubicin—thyroid cancer	0.00033	0.0014	CcSEcCtD
Dextropropoxyphene—Dermatitis—Doxorubicin—thyroid cancer	0.000329	0.0014	CcSEcCtD
Dextropropoxyphene—Headache—Doxorubicin—thyroid cancer	0.000327	0.00139	CcSEcCtD
Dextropropoxyphene—Nausea—Doxorubicin—thyroid cancer	0.000311	0.00132	CcSEcCtD
